SEC Company Response from Bionano Genomics, Inc. (BNGO) (CIK 0001411690) (BNGO) — Aug 17, 2018
Bionano Genomics, Inc. (BNGO) (CIK 0001411690)
Date: Aug. 17, 2018 · CIK: 0001411690 · Accession: 0001193125-18-251870
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-225970
Letter
Re:
Via EDGAR
August 17, 2018
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Ms. Amanda Ravitz
Bionano Genomics, Inc.
Registration Statement on Form S-1
File No. 333-225970
Acceleration Request
Requested Date:
Monday, August 20, 2018
Requested Time:
4:30 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 (File No. 333-225970) (the “Registration Statement”) to become effective on August 20, 2018, at 4:30 P.M., Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff. This request for acceleration is subject to your receiving a telephone call prior to such time from our legal counsel, Cooley LLP, confirming this request. The Registrant hereby authorizes James Pennington of Cooley LLP to make such request on its behalf. In addition, this request supersedes in its entirety the Registrant’s prior request for acceleration submitted to the Commission on August 6, 2018.
Once the Registration Statement has been declared effective, please orally confirm that event with James Pennington of Cooley LLP, counsel to the Registrant, at (858) 550-6029.
Very truly yours,
Bionano Genomics, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Via EDGAR August 17, 2018 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Ms. Amanda Ravitz Re: Bionano Genomics, Inc. Registration Statement on Form S-1 File No. 333-225970 Acceleration Request Requested Date: Monday, August 20, 2018 Requested Time: 4:30 P.M. Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 (File No. 333-225970) (the “Registration Statement”) to become effective on August 20, 2018, at 4:30 P.M., Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff. This request for acceleration is subject to your receiving a telephone call prior to such time from our legal counsel, Cooley LLP, confirming this request. The Registrant hereby authorizes James Pennington of Cooley LLP to make such request on its behalf. In addition, this request supersedes in its entirety the Registrant’s prior request for acceleration submitted to the Commission on August 6, 2018. Once the Registration Statement has been declared effective, please orally confirm that event with James Pennington of Cooley LLP, counsel to the Registrant, at (858) 550-6029. Very truly yours, Bionano Genomics, Inc. By: /s/ R. Erik Holmlin, Ph.D. R. Erik Holmlin, Ph.D. President and Chief Executive Officer cc: James Pennington, Cooley LLP Angela Dowd, Loeb & Loeb LLP